Anal Carcinoma — Trials

Anal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

88 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07085845	The Self-Sampling Pilot Study(SOLOPilot)	completed	N/A	50	Medical College of WisconsinOTHER	1	Jan 27, 2026	clinicaltrials
NCT01845779	Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal(Epitopes-HPV01)	completed	N/A	64	Centre Hospitalier Universitaire de BesanconOTHER	1	May 20, 2020